Logo image of SNDA

SONIDA SENIOR LIVING INC (SNDA) Stock Fundamental Analysis

NYSE:SNDA - New York Stock Exchange, Inc. - US1404752032 - Common Stock - Currency: USD

24.5  +0.12 (+0.49%)

After market: 24.5 0 (0%)

Fundamental Rating

1

Taking everything into account, SNDA scores 1 out of 10 in our fundamental rating. SNDA was compared to 102 industry peers in the Health Care Providers & Services industry. SNDA has a bad profitability rating. Also its financial health evaluation is rather negative. SNDA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SNDA has reported negative net income.
SNDA had a positive operating cash flow in the past year.
In the past 5 years SNDA reported 4 times negative net income.
In the past 5 years SNDA reported 4 times negative operating cash flow.
SNDA Yearly Net Income VS EBIT VS OCF VS FCFSNDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

SNDA has a Return On Assets of -5.70%. This is in the lower half of the industry: SNDA underperforms 70.59% of its industry peers.
With a Return On Equity value of -42.74%, SNDA is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -5.7%
ROE -42.74%
ROIC N/A
ROA(3y)-4.67%
ROA(5y)-8.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNDA Yearly ROA, ROE, ROICSNDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

SNDA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SNDA Yearly Profit, Operating, Gross MarginsSNDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

0

2. Health

2.1 Basic Checks

SNDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SNDA has been increased compared to 1 year ago.
SNDA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SNDA has been reduced compared to a year ago.
SNDA Yearly Shares OutstandingSNDA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
SNDA Yearly Total Debt VS Total AssetsSNDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.05, we must say that SNDA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SNDA (0.05) is worse than 77.45% of its industry peers.
SNDA has a Debt/Equity ratio of 5.78. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 5.78, SNDA is doing worse than 82.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.78
Debt/FCF N/A
Altman-Z 0.05
ROIC/WACCN/A
WACC6.9%
SNDA Yearly LT Debt VS Equity VS FCFSNDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

SNDA has a Current Ratio of 0.76. This is a bad value and indicates that SNDA is not financially healthy enough and could expect problems in meeting its short term obligations.
SNDA's Current ratio of 0.76 is on the low side compared to the rest of the industry. SNDA is outperformed by 84.31% of its industry peers.
SNDA has a Quick Ratio of 0.76. This is a bad value and indicates that SNDA is not financially healthy enough and could expect problems in meeting its short term obligations.
SNDA has a worse Quick ratio (0.76) than 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.76
SNDA Yearly Current Assets VS Current LiabilitesSNDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

SNDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.14%, which is quite impressive.
The Revenue has grown by 22.77% in the past year. This is a very strong growth!
Measured over the past years, SNDA shows a decrease in Revenue. The Revenue has been decreasing by -7.41% on average per year.
EPS 1Y (TTM)55.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.59%
Revenue 1Y (TTM)22.77%
Revenue growth 3Y9.04%
Revenue growth 5Y-7.41%
Sales Q2Q%19.1%

3.2 Future

The Earnings Per Share is expected to grow by 4.94% on average over the next years.
Based on estimates for the next years, SNDA will show a quite strong growth in Revenue. The Revenue will grow by 11.71% on average per year.
EPS Next Y-0.65%
EPS Next 2Y3.5%
EPS Next 3Y4.94%
EPS Next 5YN/A
Revenue Next Year23.94%
Revenue Next 2Y14.79%
Revenue Next 3Y11.71%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SNDA Yearly Revenue VS EstimatesSNDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
SNDA Yearly EPS VS EstimatesSNDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50 -50 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SNDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SNDA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNDA Price Earnings VS Forward Price EarningsSNDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SNDA.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.83
SNDA Per share dataSNDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.5%
EPS Next 3Y4.94%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SNDA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SONIDA SENIOR LIVING INC

NYSE:SNDA (6/5/2025, 8:10:02 PM)

After market: 24.5 0 (0%)

24.5

+0.12 (+0.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-12 2025-05-12/bmo
Earnings (Next)08-11 2025-08-11
Inst Owners79.63%
Inst Owner Change-0.28%
Ins Owners18.68%
Ins Owner Change-1.73%
Market Cap462.31M
Analysts43.33
Price Target25.5 (4.08%)
Short Float %2.27%
Short Ratio10.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.21
Dividend Growth(5Y)N/A
DP-8.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.44%
Min EPS beat(2)20.54%
Max EPS beat(2)32.34%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-23.81%
EPS NQ rev (3m)-18.18%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.97%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)12.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.17
P/FCF N/A
P/OCF 75.16
P/B 4.2
P/tB 5.26
EV/EBITDA 33.83
EPS(TTM)-3.1
EYN/A
EPS(NY)-2.8
Fwd EYN/A
FCF(TTM)-1.14
FCFYN/A
OCF(TTM)0.33
OCFY1.33%
SpS21
BVpS5.83
TBVpS4.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.7%
ROE -42.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.67%
ROA(5y)-8.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 5.78
Debt/FCF N/A
Debt/EBITDA 19.38
Cap/Depr 58.05%
Cap/Sales 7%
Interest Coverage N/A
Cash Conversion 18.73%
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.76
Altman-Z 0.05
F-Score3
WACC6.9%
ROIC/WACCN/A
Cap/Depr(3y)55.33%
Cap/Depr(5y)43.9%
Cap/Sales(3y)8.53%
Cap/Sales(5y)6.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.59%
EPS Next Y-0.65%
EPS Next 2Y3.5%
EPS Next 3Y4.94%
EPS Next 5YN/A
Revenue 1Y (TTM)22.77%
Revenue growth 3Y9.04%
Revenue growth 5Y-7.41%
Sales Q2Q%19.1%
Revenue Next Year23.94%
Revenue Next 2Y14.79%
Revenue Next 3Y11.71%
Revenue Next 5YN/A
EBIT growth 1Y12.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year656.42%
EBIT Next 3Y110.17%
EBIT Next 5YN/A
FCF growth 1Y10.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2178.15%
OCF growth 3YN/A
OCF growth 5YN/A